How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comMonoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
Description:
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have colorectal cancer.
Sponsor:
Memorial Sloan Kettering Cancer Center
Phase:
Phase 1
Contacts:
Sydney Welt, MD (STUDY_CHAIR)Government Study Link:
NCT00005616 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience